drugset / Trial / NCT01073605
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the effect of continuous and intermittent administration of Genotonorm on stature in short prepubertal children with intra-uterine growth retardation
Timeline
- Start
- 1993-07
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Somatropin | Protein / enzyme biologic | 0.03 mg/kg | Subcutaneous |
| Comparator | Somatropin | Protein / enzyme biologic | 0.06 mg/kg | Subcutaneous |
| Comparator | Somatropin | Protein / enzyme biologic | 0.7 iu/kg | Subcutaneous |
| Comparator | Somatropin | Protein / enzyme biologic | 1.4 iu/kg | Subcutaneous |